Refractory livedoid vasculopathy successfully treated with baricitinib

Yue Xiao^#¹, Yiyi Wang^#¹, Yuanxia Gu¹, Dengmei Xia^{1

2}, Wei Li¹

Affiliations

¹ Department of Dermatology and Venereology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
² Department of Dermatology, The Affliated Hospital of Southwest Medical University, Luzhou, China.

^# Contributed equally.

Comment

Yue Xiao et al. Int J Dermatol. 2023 Sep.

. 2023 Sep;62(9):1204-1205.

doi: 10.1111/ijd.16467. Epub 2022 Nov 8.

Yue Xiao^#¹, Yiyi Wang^#¹, Yuanxia Gu¹, Dengmei Xia^{1

2}, Wei Li¹

¹ Department of Dermatology and Venereology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
² Department of Dermatology, The Affliated Hospital of Southwest Medical University, Luzhou, China.

^# Contributed equally.

No abstract available

Comment on

Treatment of Livedoid Vasculopathy With Baricitinib.
Song X, Tu P. Song X, et al. JAMA Dermatol. 2022 May 1;158(5):587-589. doi: 10.1001/jamadermatol.2022.0241. JAMA Dermatol. 2022. PMID: 35353137 No abstract available.